Probiotics and infantile atopic eczema

Area of Science:

• Allergy and Immunology
• Pediatric Dermatology
• Microbiology

Background:

• Pediatric eczema is a prevalent condition with significant societal and economic impacts.
• It often serves as an initial allergic manifestation in children, potentially preceding other atopic diseases like asthma.
• Recent increases in eczema incidence drive research into its epidemiology, prevention, and treatment.

Purpose of the Study:

• To review the current evidence on the role of probiotics in preventing and treating pediatric atopic eczema.
• To evaluate the safety and potential benefits of probiotic administration during pregnancy and infancy for eczema prevention.
• To identify knowledge gaps and future research directions for probiotic use in pediatric eczema.

Main Methods:

• Systematic review of existing studies on probiotics and pediatric eczema.
• Analysis of evidence regarding probiotic efficacy, optimal timing, dosage, and specific strains.
• Evaluation of safety data for probiotic use in pregnant women and infants.

Main Results:

• Current evidence for probiotics preventing pediatric eczema is not robust, with potential effects dependent on specific factors like strain, dose, and duration.
• There is insufficient evidence to support the use of probiotics for treating established eczema.
• Probiotic administration to breastfeeding mothers and infants appears to be a safe option for eczema prevention.

Conclusions:

• While probiotics may offer a safe adjunctive strategy for eczema prevention, particularly prenatally and postnatally, their role in treatment remains unproven.
• Further research is needed to clarify the specific conditions under which probiotics may be effective.
• The clinical application of probiotics for pediatric eczema is expected to grow as more definitive answers emerge.